ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p871.xmlRisk Factors for the Assessment of Patients with Pulmonary Embolism2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p871.pdf2026-04-18Risk Factors for the Assessment of Patients with Pulmonary Embolismhttps://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p831.xmlA New NCCN Guideline: Venous Thromboembolic Disease2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p831.pdf2026-04-18A New NCCN Guideline: Venous Thromboembolic Diseasehttps://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p838.xmlVenous Thromboembolic Disease2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p941.xmlIntraperitoneal Chemotherapy for Ovarian Cancer: Where Are We Now?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p941.pdf2026-04-18Intraperitoneal Chemotherapy for Ovarian Cancer: Where Are We Now?https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p889.xmlCatheter-Related Thrombosis: Risks, Diagnosis, and Management2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p889.pdf2026-04-18Catheter-Related Thrombosis: Risks, Diagnosis, and Managementhttps://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p903.xmlLong-Term Therapy of Venous Thromboembolism in Cancer Patients2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p903.pdf2026-04-18Long-Term Therapy of Venous Thromboembolism in Cancer Patientshttps://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p881.xmlInferior Vena Cava Filters in the Cancer Patient: Current Use and Indications2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p881.pdf2026-04-18Inferior Vena Cava Filters in the Cancer Patient: Current Use and Indicationshttps://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p912.xmlOvarian Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p947.xmlRational Use of Cytotoxic Chemotherapy for Recurrent Ovarian Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p947.pdf2026-04-18Rational Use of Cytotoxic Chemotherapy for Recurrent Ovarian Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p955.xmlNovel Non-Cytotoxic Therapy in Ovarian Cancer: Current Status and Future Prospects2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/4/9/article-p955.pdf2026-04-18Novel Non-Cytotoxic Therapy in Ovarian Cancer: Current Status and Future Prospects